{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:46:07Z","timestamp":1790077567369,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":5562,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1093\/annonc\/mdh392","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T19:28:40Z","timestamp":1095190120000},"page":"1467-1475","source":"Crossref","is-referenced-by-count":306,"title":["Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification"],"prefix":"10.1016","volume":"15","author":[{"given":"K.J.","family":"Savage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chhanabhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Gascoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh392_bb0010","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh392_bb0015","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project","volume":"49","author":"Anonymous","year":"1982","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh392_bb0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas [letter]","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdh392_bb0025","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh392_bb0030","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of ematopoetic and Lymphoid Tissues","first-page":"189","article-title":"Mature T-cell and NK-cell neoplasms","author":"Banks","year":"2001"},{"key":"10.1093\/annonc\/mdh392_bb0035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/10428199209049801","article-title":"Clinical and biological analysis of peripheral T-cell lymphomas: a single institution study","volume":"7","author":"Haioun","year":"1992","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdh392_bb0040","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1200\/JCO.1991.9.8.1426","article-title":"Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience","volume":"9","author":"Kwak","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh392_bb0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1200\/JCO.1989.7.6.725","article-title":"Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades\u2013should peripheral T-cell lymphoma be considered separately?","volume":"7","author":"Cheng","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh392_bb0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10428199609045720","article-title":"Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas","volume":"24","author":"Karakas","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdh392_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","article-title":"Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives)","volume":"1","author":"Coiffier","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh392_bb0060","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","article-title":"Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma","volume":"89","author":"Melnyk","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh392_bb0065","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh392_bb0070","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification","volume":"9","author":"Lopez-Guillermo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh392_bb0075","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.267.5196.316-b","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma [letter","volume":"267","author":"Morris","year":"1995","journal-title":"Science"},{"key":"10.1093\/annonc\/mdh392_bb0080","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","article-title":"Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma","volume":"93","author":"Gascoyne","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh392_bb0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.1331","article-title":"ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects\u2013a review","volume":"200","author":"ten Berge","year":"2003","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/mdh392_bb0090","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma: The International NHL Prognostic Factors Project","volume":"329","author":"Shipp","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh392_bb0095","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","article-title":"Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma","volume":"15","author":"Ansell","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh392_bb0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdh392_bb0105","first-page":"185","article-title":"Asymptotically efficient rank invarian test procedures","volume":"135","author":"Peto","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1093\/annonc\/mdh392_bb0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ajcp\/108.3.295","article-title":"Clinical utility of heteroduplex analysis of TCR gamma gene rearrangements in the diagnosis of T-cell lymphoproliferative disorders","volume":"108","author":"Chhanabhai","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdh392_bb0115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ajcp\/103.4.472","article-title":"Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma","volume":"103","author":"Horsman","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdh392_bb0120","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Hematopoetic and Lymphoid Tissues","year":"2001"},{"key":"10.1093\/annonc\/mdh392_bb0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2002-05-1352","article-title":"Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL","volume":"103","author":"Tsuchiya","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh392_bb0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh392_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0959-8049(01)00344-6","article-title":"Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American Lymphoma (REAL) classification","volume":"38","author":"Kim","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdh392_bb0140","first-page":"2474","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"10","author":"Gallamini","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh392_bb0145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3322\/canjclin.47.6.323","article-title":"The changing classification of non-Hodgkin's lymphomas [editorial]","volume":"47","author":"Armitage","year":"1997","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mdh392_bb0150","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0889-8588(05)70466-4","article-title":"Pathologic prognostic factors in diffuse aggressive non-Hodgkin's lymphoma","volume":"11","author":"Gascoyne","year":"1997","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1093\/annonc\/mdh392_bb0155","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0037-1963(03)00138-0","article-title":"Systemic and primary cutaneous anaplastic large cell lymphomas","volume":"40","author":"Kadin","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1093\/annonc\/mdh392_bb0160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/10428199909058412","article-title":"Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature","volume":"32","author":"Pautier","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdh392_bb0165","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh392_bb0170","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00000478-199304000-00010","article-title":"Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection","volume":"17","author":"Arber","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdh392_bb0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","article-title":"Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality","volume":"54","author":"Cheung","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdh392_bb0180","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh392_bb0185","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1023\/A:1008439620513","article-title":"Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomas","volume":"9","author":"Campo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh392_bb0190","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00277-002-0556-2","article-title":"Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation","volume":"81","author":"Kahl","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1093\/annonc\/mdh392_bb0195","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","article-title":"Impact of high-dose chemotherapy on peripheral T-cell lymphomas","volume":"19","author":"Rodriguez","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh392_bb0200","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","article-title":"High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas","volume":"27","author":"Blystad","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdh392_bb0205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1701596","article-title":"Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT)","volume":"23","author":"Fanin","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdh392_bb0210","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1023\/A:1008409601731","article-title":"Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients","volume":"9","author":"Zinzani","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh392_bb0215","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1080\/1042819022386806","article-title":"Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma","volume":"43","author":"Huang","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdh392_bb0220","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood.V98.9.2865","article-title":"Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report","volume":"98","author":"Piekarz","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh392_bb0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh392_bb0230","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":"Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdh392_bb0235","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh392_bb0240","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2002-11-3574","article-title":"Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study","volume":"102","author":"Tracey","year":"2003","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341951047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341951047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/10\/1467\/406812\/mdh392.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T18:20:27Z","timestamp":1582222827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341951047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S092375341951047X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh392","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}